Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Chinese Patients With Moderate to Severe Crohn's Disease
CTR20150507Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jul 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in Crohn's disease, sponsored by Abbott Laboratories. Started Jul 2015; status: completed.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on CTR20150507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150507.